Related Experiment Video
Updated: May 21, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?
Ian S Stone1, Neil C Barnes, Steffen E Petersen
1Centre for Advanced Cardiovascular Imaging, William Harvey Research Institute, Barts and the London National Institute of Health Research Biomedical Research Unit, The London Chest Hospital, Bonner Road, London E2 9JX, UK.
Heart (British Cardiac Society)
|June 29, 2012
Summary
Patients with chronic obstructive pulmonary disease (COPD) face significant cardiac risks. Emerging evidence suggests COPD treatments may offer cardio-protection, highlighting the need for further research into underlying mechanisms.
Area of Science:
- Cardiology
- Pulmonology
- Public Health
Background:
- Chronic obstructive pulmonary disease (COPD) is associated with substantial cardiac morbidity and mortality.
- Shared risk factors like age, smoking, and pollution contribute, alongside inappropriate beta-blocker under-prescribing.
- Beyond conventional factors, independent mechanisms like inflammation and pulmonary hypertension are implicated in COPD-related cardiovascular risk.
Purpose of the Study:
- To review current evidence on hypotheses linking COPD to cardiovascular disease.
- To explore how modulating these factors may prevent cardiovascular events in COPD patients.
- To emphasize the clinical significance of COPD underdiagnosis and the need for mechanistic studies.
Main Methods:
- Review of current evidence from randomized controlled trials and existing literature.
- Analysis of proposed pathophysiological links between COPD and cardiovascular disease.
- Discussion of potential therapeutic interventions targeting identified mechanisms.
Main Results:
- Evidence suggests COPD treatments may possess cardio-protective properties.
- Inflammation, pulmonary hypertension, lung hyperinflation, and genetics are key hypotheses for increased cardiovascular risk in COPD.
- Modulating these factors presents a potential strategy for cardiovascular risk reduction.
Conclusions:
- COPD treatment may offer cardiovascular benefits, warranting further investigation.
- Addressing COPD underdiagnosis is crucial to mitigate associated cardiovascular consequences.
- Mechanistic studies are essential to understand and optimize interventions for cardiovascular protection in COPD.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...